(NAFLD) Recruiting Phase 2 Trials for Saroglitazar (DB13115)

Also known as: NAFLD

IndicationStatusPhase
DBCOND0039962 ((NAFLD))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03639623Safety, Tolerability and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With NAFLDTreatment